Global X Aging Population ETF Rating → America’s worst nightmare? (From Porter & Company) (Ad) Free AGNG Stock Alerts $29.86 +0.28 (+0.95%) (As of 05/14/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Global X Aging Population ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy2.65Holdings in AGNG have an aggregate rating of Moderate Buy based on 416 analyst ratings issued in the past year covering 30 companies (55.3% of the portfolio).AGNG Aggregate Price Target$33.4612.07% UpsideHigh Prediction$40.39Average Prediction$33.46Low Prediction$26.36Holdings in AGNG have an aggregate price target of $33.46 and a range of $26.36 to $40.39 covering 30 companies (55.3% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 AGNG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.31%AZNAstraZeneca$77.04-0.5%2 of 5 stars2.57$81.00 5.1%73.25%BSXBoston Scientific$73.47+0.9%4 of 5 stars2.95$75.09 2.2%21Insider SellingShort Interest ↑3.19%WELLWelltower$98.82-0.7%4 of 5 stars2.79$96.07 -2.8%14Analyst Downgrade3.05%AMGNAmgen$311.41+1.0%5 of 5 stars2.52$305.65 -1.8%213.00%JNJJohnson & Johnson$151.36+0.1%5 of 5 stars2.46$175.86 16.2%13Short Interest ↑2.96%SYKStryker$324.30-0.1%5 of 5 stars2.78$365.94 12.8%18Dividend Announcement2.96%MDTMedtronic$84.29+0.9%5 of 5 stars2.40$94.91 12.6%102.95%LLYEli Lilly and Company$763.89+0.8%5 of 5 stars2.84$769.53 0.7%19Analyst ForecastShort Interest ↓2.93%REGNRegeneron Pharmaceuticals$984.64+0.8%4 of 5 stars2.71$989.36 0.5%21Analyst ForecastPositive News2.91%ABBVAbbVie$161.55+0.2%4 of 5 stars2.77$174.31 7.9%13Short Interest ↑2.89%EWEdwards Lifesciences$86.46+2.1%5 of 5 stars2.58$93.88 8.6%19Analyst UpgradeInsider SellingShort Interest ↑2.79%BMYBristol-Myers Squibb$44.73-0.7%5 of 5 stars2.11$60.00 34.1%19Short Interest ↓Analyst Revision2.72%DXCMDexCom$125.97+0.8%5 of 5 stars2.93$141.67 12.5%14Short Interest ↓Positive News2.26%ZBHZimmer Biomet$119.97+0.3%5 of 5 stars2.29$135.40 12.9%14Dividend Announcement1.64%VTRVentas$47.96+0.7%4 of 5 stars2.75$51.25 6.9%12Dividend AnnouncementInsider Selling1.36%BGNEBeiGene$160.77-0.9%3 of 5 stars2.80$251.93 56.7%10Earnings ReportAnalyst Revision1.25%NBIXNeurocrine Biosciences$138.48+1.7%5 of 5 stars2.75$148.96 7.6%24Analyst Forecast1.08%DVADaVita$137.01+0.3%4 of 5 stars2.33$129.75 -5.3%3Insider Selling1.07%INCYIncyte$57.05-1.0%5 of 5 stars2.47$74.93 31.3%17Short Interest ↑1.07%PODDInsulet$172.27+7.0%5 of 5 stars2.82$239.44 39.0%17Earnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume1.02%UTHRUnited Therapeutics$269.78+2.1%5 of 5 stars2.90$308.78 14.5%10Insider SellingPositive News0.99%EXASExact Sciences$54.00-2.9%5 of 5 stars2.92$95.40 76.7%13Short Interest ↓Analyst Revision0.90%TFXTeleflex$212.62+2.7%5 of 5 stars2.67$261.75 23.1%9Short Interest ↓Analyst Revision0.70%OHIOmega Healthcare Investors$30.86+0.4%4 of 5 stars2.46$33.63 9.0%13Positive News0.66%EXELExelixis$20.99-1.3%5 of 5 stars2.59$26.13 24.5%17Analyst ForecastShort Interest ↑0.61%ENSGThe Ensign Group$118.14+0.3%4 of 5 stars2.80$124.60 5.5%5Positive News0.52%BPMCBlueprint Medicines$105.46-2.4%1 of 5 stars2.53$102.65 -2.7%17Analyst ForecastShort Interest ↑0.45%GKOSGlaukos$110.96+2.4%3 of 5 stars2.82$108.64 -2.1%11Insider SellingShort Interest ↑0.45%HALOHalozyme Therapeutics$43.82+0.5%5 of 5 stars2.83$53.14 21.3%60.39%MMSIMerit Medical Systems$82.40+1.9%5 of 5 stars2.89$92.78 12.6%9 This page (NASDAQ:AGNG) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
